Journal of the Pancreas Open Access

  • ISSN: 1590-8577
  • Journal h-index: 79
  • Journal CiteScore: 29.12
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Editorial Panel

Ashraf Mustafa Rasheed, University of South Wales, United Kingdom

Muhammad Wasif Saif, Deputy Physician-in Chief Director,Professor
Medical Oncology Northwell Health Cancer Institute.Feinstein Institute for Medictial Research. Professor Medical Onclogy, Zucker School of Medicine, USA

Abbas Agaimy, University of Erlangen-Nuremberg, Germany

View More

Submit Manuscript

Submit manuscript at www.primescholars.com/submissions/jop-pancreas.html or send as an e-mail attachment to the Editorial Office at [email protected]

About the Journal

H Index: 44 |

Google Scholar h5 index: 25 |

Index Copernicus Value 2015: 111.45 |

ResearchGate Impact: 1.04*

Next issue will be published in November 2022
Current Issue: Volume 23, Issue 10 

Clarivate Analytics JOP. Journal of the Pancreas is covered in the Emerging Sources Citation Index, which means all articles published in the journal are indexed in Web of Science at the time of publication.

You may submit manuscripts online at https://www.primescholars.com/submissions/jop-pancreas.html (or) By E-mail [email protected]

JOP. Journal of the Pancreas publishes multidisciplinary research that covers theory and practice in all the related fields of pancreatic diseases and therapy.

JOP is a peer-reviewed and an open access journal publishes manuscripts bi-monthly on relevant topics including etiology, epidemiology, prevention, genetics, pathophisiology, diagnosis, surgical and medical management of pancreatic diseases including cancer, inflammatory diseases, diabetes mellitus, clinical pancreatology, internal medicine, clinical research, gastrointestinal surgery, endocrinology, hepatology, management of acute pancreatitis, diabetes, pancreatic ductal adenocarcinoma and its treatments, chronic pancreatitis, neuroendocrine tumor, cystic fibrosis and other congenital disorders.

The submissions include original research, case studies, innovations in program development, scholarly reviews, theoretical discourse and book reviews. Additionally, the Journal encourages submission of responsible speculations and commentary. JOP. Journal of the Pancreas provides topical reviews and updates relevant to pancreatic anomalies and therapy along with ongoing annotated research reviews published elsewhere, making the Journal a unique and valuable reference resource. The editorial board consists of a panel of international luminaries entrusted with the task of providing the readership the state-of-the-art information that will be of great value to all that function within the field of pancreatic research.

The JOP. Journal of Pancreas follows single blind peer review process for validating the quality and worth of each received manuscript. Review process is performed under the aegis of the Editorial Board members of the Journal. After primary quality check each article is reviewed by the outside experts under the guidance of the assigned Editor. At least two independent reviewers approval followed by Editor approval is mandatory for acceptance of any submission.

Citation
The journal is indexed in: EBSCO, CNKI, ICMJE, THOMSON REUTERS ESCI (EMERGING SOURCES CITATION INDEX), COSMOS, BRITISH LIBRARY and University of Zurich - UZH

Associated With

Pancreatitis Supporters Network
Greek Society for Liver Pancreas and Biliary
Belarusian Pancreatic Club

Open Access Statement

This is an open access journal which allows all content available freely without any charge to the individual user or any Institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without any prior permission from the publisher or the author provided the author is given due credit wherever necessary. This is in accordance with the BOAI definition of open access..

Swift Review Process and Editorial Execution (FEE-Review Process)

Our journal is taking part in the Fast Editorial Execution and Review Process (Charge-Review Process), which requires an additional prepayment of $99 in addition to the standard article processing fee. Fast Editorial Execution and Review Process is a distinctive service for the article that allows it to receive a rapid response from the handling editor in the pre-review stage as well as a review from the reviewer. An author can expect a pre-review answer within 3 days after submission, a review process by the reviewer within 5 days, and revision/publication within 2 days. If the handling editor notifies the article for revision, it will take another 5 days for external review by the former reviewer or alternative reviewer.

Acceptance of papers for rapid review is solely driven by editorial team considerations and independent peer-review, ensuring the highest standards are maintained regardless of the route to conventional peer-reviewed publication or a rapid editorial review procedure. The article's contributor and the editor office are both accountable for conforming to scientific standards. Even if the article is rejected or withdrawn for publication, the $99 FEE-Review process will not be returned.

Payment for the manuscript FEE-Review Process is the responsibility of the related author or institution/organization. Regular article publication includes preparation in various formats for online publication, ensuring full-text inclusion in a number of permanent archives such as HTML, XML, and PDF, and feeding to various indexing agencies.

h-index

Articles published in Journal of the Pancreas have been cited by esteemed scholars and scientists all around the world. Journal of the Pancreas has got h-index 79 , which means every article in Journal of the Pancreas has got 79 average citations.

Journal Highlights

Current Issue Highlights